This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Stocks in Motion

Icoria (ICOR) fell 20.1% after the company said it would be delisted from the Nasdaq SmallCap market on June 30 for failing to meet or exceed Nasdaq's minimum $1 bid price requirement for 180 calendar days. "We have anticipated this decision by the Nasdaq and our board of directors has decided not to appeal or consider options such as a reverse stock split," the company said. Shares of the biotechnology company traded down 6 cents to 23 cents.

Shares of Pfizer (PFE - Get Report) rose modestly after the company said that it would buy up to $5 billion in stock. The company, which recently completed a $5 billion repurchase plan, said the new buyback plan "capitalizes on Pfizer's financial and operational strength to increase shareholder value." Shares traded up 11 cents to $28.90.

Other health care volume movers included Merck (MRK - Get Report), down 73 cents to $31.25; Schering-Plough (SGP), up 22 cents to $20.35; Johnson & Johnson (JNJ - Get Report), down 65 cents to $65.34; Elan (ELN), down 25 cents to $6.68; Amgen (AMGN), down 12 cents to $60.76; Millennium Pharmaceuticals (MLNM), down 7 cents to $9.09; Momenta Pharmaceuticals (MNTA), up $2.82 to $19.50; Guidant (GDT), down 55 cents to $68.60; and Bristol-Myers Squibb (BMY), down 15 cents to $25.50.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ABI $22.98 1.01%
ELN $0.00 0.00%
ICOR $0.06 0.00%
JNJ $112.75 0.00%
MRK $55.30 0.00%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs